Celebrating 15 Years of the TREAT-NMD Advisory committee for therapeutics (TACT): A Milestone Event in Boston

31 October 2024

This year marks the 15th anniversary of the TREAT-NMD Advisory committee for therapeutics (TACT). TACT was set up in 2009 by Prof. Volker Straub and Kate Bushby to provide the neuromuscular community with a unique drug development resource. The aim is to give transparent and consistent guidance to the neuromuscular research community in order to advance the treatment of neuromuscular diseases more effectively. Each year the committee meets in the spring and the autumn, and a bespoke panel is assembled to review up to four applications for advice from organisations developing treatments in NMD.

To celebrate 15 years of successful TACT meetings we are very happy to announce some additional events which will take place at the Autumn meeting. Scheduled for October 31st, we will host our very first symposium by the advisory committee: “Developing Therapies in Rare Neuromuscular Disease,”. This symposium promises a day filled with insightful talks, reflecting on the wealth of knowledge gleaned over the past 15 years of TACT’s operation.

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern